388 related articles for article (PubMed ID: 24180669)
1. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
Rubini G; Nicoletti A; Rubini D; Asabella AN
Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
[TBL] [Abstract][Full Text] [Related]
2. Radium-223 dichloride in clinical practice: a review.
Florimonte L; Dellavedova L; Maffioli LS
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689
[TBL] [Abstract][Full Text] [Related]
3. The management of painful bone metastases with an emphasis on radionuclide therapy.
Hillegonds DJ; Franklin S; Shelton DK; Vijayakumar S; Vijayakumar V
J Natl Med Assoc; 2007 Jul; 99(7):785-94. PubMed ID: 17668645
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
Bauman G; Charette M; Reid R; Sathya J
Radiother Oncol; 2005 Jun; 75(3):258-70. PubMed ID: 16299924
[TBL] [Abstract][Full Text] [Related]
5. [Bone metastases treated with radiopharmaceuticals].
Giammarile F
Bull Cancer; 2013 Nov; 100(11):1223-7. PubMed ID: 24409472
[TBL] [Abstract][Full Text] [Related]
6. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
Pandit-Taskar N; Batraki M; Divgi CR
J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
[TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
[TBL] [Abstract][Full Text] [Related]
8. The use of radioisotopes for palliation of metastatic bone pain.
Gkialas I; Iordanidou L; Galanakis I; Giannopoulos S
J BUON; 2008; 13(2):177-83. PubMed ID: 18555462
[TBL] [Abstract][Full Text] [Related]
9. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
Badawi JK
Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
[TBL] [Abstract][Full Text] [Related]
10. Clinical dosimetry in the treatment of bone tumors: old and new agents.
Hindorf C; Flux GD; Ibisch C; Kraeber Bodéré F
Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):198-204. PubMed ID: 21386790
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.
Guerra Liberal FD; Tavares AA; Tavares JM
Med Phys; 2014 Nov; 41(11):114101. PubMed ID: 25370676
[TBL] [Abstract][Full Text] [Related]
12. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.
Pandit-Taskar N; Larson SM; Carrasquillo JA
J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987
[TBL] [Abstract][Full Text] [Related]
13. [Radionuclide therapy for bone metastases by drugs based on Re-188].
Liepe K; Krylov VV; Kochetova TY
Vopr Onkol; 2016; 62(4):401-9. PubMed ID: 30474946
[TBL] [Abstract][Full Text] [Related]
14. Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain.
Paes FM; Serafini AN
Semin Nucl Med; 2010 Mar; 40(2):89-104. PubMed ID: 20113678
[TBL] [Abstract][Full Text] [Related]
15. Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases.
Lam MG; de Klerk JM; van Rijk PP; Zonnenberg BA
Anticancer Agents Med Chem; 2007 Jul; 7(4):381-97. PubMed ID: 17630915
[TBL] [Abstract][Full Text] [Related]
16. 186Re-HEDP for metastatic bone pain in breast cancer patients.
Lam MG; de Klerk JM; van Rijk PP
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
Porter AT; Ben-Josef E; Davis L
Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173
[TBL] [Abstract][Full Text] [Related]
18. [Targeted radionuclide therapy for castration-resistant prostate cancer].
Nakamura K; Ohga S; Sasaki T; Baba S; Honda H
Nihon Rinsho; 2014 Dec; 72(12):2181-5. PubMed ID: 25518355
[TBL] [Abstract][Full Text] [Related]
19. Bone-targeting radiopharmaceuticals including radium-223.
Brady D; Parker CC; O'Sullivan JM
Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760
[TBL] [Abstract][Full Text] [Related]
20. Bone-targeted therapies to reduce skeletal morbidity in prostate cancer.
Dorff TB; Agarwal N
Asian J Androl; 2018; 20(3):215-220. PubMed ID: 29553053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
